Effect of Jun N-terminal kinase 1 and 2 on the replication of Penicillium marneffei in human macrophages

Microbial Pathogenesis
Renqiong ChenGuangquan Ji

Abstract

Penicillium marneffei (P. marneffei) is a human pathogen which persists in macrophages and threatens the immunocompromised patients. To clarify the mechanisms involved, we evaluated the effect of c-Jun N-terminal kinase 1 and 2 (JNK1/2) on cytokine expression, phagosomal maturation and multiplication of P. marneffei in P. marneffei-stimulated human macrophages. P. marneffei induced the rapid phosphorylation of JNK1/2. Using the specific inhibitor of JNK1/2 (SP600125), we found that the inhibition of JNK1/2 suppressed P. marneffei-induced tumor necrosis factor-α and IL-10 production. In addition, the presence of SP600125 increased phagosomal acidification and maturation and decreased intracellular replication. These data suggest that JNK1/2 may play an important role in promoting the replication of P. marneffei. Our findings further indicate that the pathogen through the JNK1/2 pathway may attenuate the immune response and macrophage antifungal function.

References

Mar 1, 1995·Trends in Biochemical Sciences·E Cano, L C Mahadevan
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T A Duong
Nov 30, 1998·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·T Sirisanthana, K Supparatpinyo
Sep 5, 2002·FEMS Immunology and Medical Microbiology·Asima BhattacharyyaJoyoti Basu
Mar 5, 2003·Cellular Microbiology·Jeffrey S Schorey, Andrea M Cooper
Mar 20, 2003·Immunology Letters·Pio ContiTheoharis C Theoharides
Jan 19, 2006·Clinical Microbiology Reviews·Nongnuch VanittanakomThira Sirisanthana
Jan 15, 2008·Current Opinion in Infectious Diseases·Andrew P UstianowskiJeremy N Day
Feb 5, 2011·Emerging Infectious Diseases·Cunwei CaoMatthew C Fisher
Jan 15, 2014·PloS One·Alessandra A FilardyGeorge A DosReis

❮ Previous
Next ❯

Citations

Aug 15, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Paschalis VergidisTitus Augustine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Brucellosis (ASM)

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Brucellosis

Brucellosis is a bacterial infection caused by members of the genus brucella and remains one of the world's major zoonotic diseases. Discover the latest research on Brucellosis here.